{
  "@context": {
    "@vocab": "http://schema.org/",
    "rdau": "http://rdaregistry.info/Elements/u/",
    "skos": "http://www.w3.org/2004/02/skos/core#",
    "skos:prefLabel": {
      "@container": "@language"
    }
  },
  "@graph": [
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00128382800",
      "contributor": {
        "@id": "http://urn.fi/URN:NBN:fi:au:pn:000042672"
      },
      "name": "Diabetesläkemedel i Norden : analys av orsaker till variationer i förbrukningen"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:bib:me:W00303678800",
      "author": {
        "@id": "http://urn.fi/URN:NBN:fi:au:pn:000042672"
      },
      "name": "The relationship between gastric inhibitory polypeptide (GIP) and beta-cell function in man"
    },
    {
      "@id": "http://urn.fi/URN:NBN:fi:au:pn:000042672",
      "@type": "Person",
      "name": "Groop, Per-Henrik"
    }
  ]
}